USP30
MOLECULAR TARGETubiquitin specific peptidase 30
USP30 (ubiquitin specific peptidase 30) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting USP30
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Gliotoxin | 1.10 | 2 |
| 2 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 0.69 | 1 |
| 3 | Quercetin | 0.69 | 1 |
| 4 | alpha-Linolenic Acid | 0.69 | 1 |
| 5 | salvin [Supplementary Concept] | 0.69 | 1 |
| 6 | carnosol | 0.69 | 1 |
| 7 | Nigericin | 0.69 | 1 |
| 8 | piceatannol | 0.69 | 1 |
| 9 | prunetin | 0.69 | 1 |
| 10 | withaferin | 0.69 | 1 |
About USP30 as a Drug Target
USP30 (ubiquitin specific peptidase 30) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented USP30 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
USP30 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.